论文部分内容阅读
目的探讨双歧杆菌三联活菌散预防和治疗小儿肺炎继发性腹泻的临床价值。方法整取抽样2014年1月-2016年1月本院收治的肺炎患儿240例,按随机数字表法分为2组,对照组120例,给予常规治疗,观察组120例,在常规治疗基础上联合双歧杆菌三联活菌散治疗,均治疗7d,观察两组腹泻发生情况、腹泻严重程度及用药不良反应发生情况。结果观察组治疗3d、5d、7d腹泻发生率均低于对照组(P<0.05);且观察组腹泻程度较轻,无明显不良反应发生,与对照组比较(P<0.05)。结论对小儿肺炎继发性腹泻患者采取双歧杆菌三联活菌散治疗的效果较好,能改善患儿腹泻症状。
Objective To investigate the clinical value of triple antibiotic bifidobacterium triple in prevention and treatment of secondary diarrhea in children with pneumonia. Methods Total sampling 240 patients with pneumonia admitted to our hospital from January 2014 to January 2016 were randomly divided into two groups according to random number table method and 120 patients in the control group. All patients were given conventional therapy and 120 patients in the observation group were treated with conventional therapy Based on the combination of Bifidobacterium triple live bacteria scattered treatment, were treated for 7 days, observed the incidence of diarrhea in both groups, the severity of diarrhea and adverse drug reactions occurred. Results The incidence of diarrhea in the observation group was significantly lower than that in the control group on the 3rd, 5th and 7th day (P <0.05). The degree of diarrhea in the observation group was mild and no obvious adverse reactions occurred, compared with the control group (P <0.05). Conclusion The treatment of children with secondary pneumonia secondary diarrhea Bifidobacterium triple active Bacillus powder treatment is better, can improve the symptoms of children with diarrhea.